Concepedia

A. Cirstoiu-Hapca

AC

Statistics

Publications

3

Citations

284

H-Index

3

Active since

2006

Affiliations

University Hospital of Geneva(Current)

University of Geneva

University of Lausanne

A. Cirstoiu-Hapca is an author at University Hospital of Geneva specializing in nanomedicine, cancer nanomedicine, and pharmacy.

Publications per year

2006–2010

3

Publications

3

Differential tumor cell targeting of anti-HER2 (Herceptin®) and anti-CD20 (Mabthera®) coupled nanoparticles

A. Cirstoiu-Hapca, L. Bossy-Nobs, F. Buchegger et al. · International Journal of Pharmaceutics · 2006 · 111 citations

, , +12

Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice

A. Cirstoiu-Hapca, F. Buchegger, Norbert Lange et al. · Journal of Controlled Release · 2010 · 103 citations

, , +16

Nanomedicines for active targeting: Physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells

A. Cirstoiu-Hapca, F. Buchegger, Leila Bossy et al. · European Journal of Pharmaceutical Sciences · 2009 · 70 citations

, , +17

1–3 of 3